Objective: To describe the characteristics of neonates admitted to intensive care unit (ICU) and their outcome in a tertiary care paediatric hospital in Bangladesh. Study Design: Retrospective, descriptive study. Setting and Duration of Study: Paediatric intensive care unit in Dhaka Shishu Hospital from January to December 2011. Methods: Data was retrieved from file records of all admitted neonates regarding age, gender, gestational age, birth and admission weight, reason for admission and outcome. Results: During this study period, the total number of patients admitted was 191; most of them were neonates (146, 76.4%). Among the 146 neonates, the highest number comprised of birth asphyxia (55, 37.7%), followed by serious bacterial infections (sepsis, pneumonia, meningitis) (30, 20.5%) preterm low birth weight (LBW) babies (28, 19.2%), surgical conditions (congenital diaphragmatic hernia, oesophageal atresia with trachea-oesophageal fistula, Hirschsprung disease and anorectal malformations) (18, 12.3%), respiratory distress syndrome (RDS) (9, 6.2%), and congenital heart disease (6, 4.1%). Out of 146 patients, 42 expired (28.8%). Most of the expiries were due to sepsis (35.7%); followed by prematurity (21.4%), perinatal asphyxia (19.0%) and surgical conditions (14.3%). Conclusion: Birth asphyxia, septicaemia, and prematurity were the main reasons for neonatal admissions in ICU, while case fatality was highest for septicaemia. Regular antenatal visits, safe delivery practice and timely referral to tertiary care hospitals may result in decreased burden in ICU and also better outcome. DOI: http://dx.doi.org/10.3329/jbcps.v31i3.20979 J Bangladesh Coll Phys Surg 2013; 31: 134-139
Abstract:Glomus tumors are benign hamartoma of glomus body. It accounts 1-5% of all soft tissue tumors of hand. They can cause recurrent episodes of intense lancinating pain and disability. Patients often undergo undiagnosed or misdiagnosed for many years because the tumors are small. Twenty patients were operated during the period of 2010 to 2015. Most of the cases were selected on the basis of clinical diagnosis. The help of magnetic resonance imaging was taken in suspicious cases. The only treatment of glomus tumor is total surgical excision. In this study surgical excision were performed by direct trans-ungual approach. All patients showed dramatic relief of pain after surgical excision. Early diagnosis and surgical excision decreases patient's sufferings from severe pain and disability. Eagerness in early diagnosis and surgical excision can reduce long period of sufferings.
Pain, nausea, vomiting, oedema and poor oral intake are the most common morbidities after general anesthesia and surgery like tonsillectomy. This study was done to evaluate the effectiveness of intravenous dexamethasone (0.15mg/kg) at induction of anaesthesia on post tonsillectomy morbidities. In this prospective randomized double blind study, sixty children of age between 8-12 years, ASA I & II undergoing tonsillectomy under general anaesthesia were randomly assigned into two equal groups of 30 each. They received dexamethasone IV or saline (control) following induction of anaesthesia. Both anesthetic and surgical techniques were standardized. Post operative pain was assessed by visual analogue scale (VAS). Inj. Tramadol 1mg/kg in first 6 hrs and oral paracetamol 10mg/kg in next 24 hrs were administered as rescue analgesic. Incidence of nausea, vomiting, time and quantity of first oral intake were also noted. Patients receiving dexamethasone experienced significantly less pain, nausea and vomiting than control group throughout 24 hrs. Lesser patients required rescue analgesics (23.33% vs. 46.67%) in first 6 hrs. So, it is found that, single intravenous dose of dexamethasone (0.15mg/kg) provided significant analgesia, reduced nausea, vomiting and improved quality of oral intake in paediatric patients who underwent tonsillectomy. Journal of BSA, Vol. 20, No. 1, January 2007 p.13-17
Giant cell tumour of bone (GCT) has been characterized as benign but often locally aggressive neoplasm that commonly occurs in proximity to weight bearing bone. Management of giant cell tumor of bone by curettage and bone cement in weight bearing bone is an effective method. This prospective experimental study was conducted among the patients with histologically proved giant-cell tumour who were admitted in the Department of orthopedic surgery, Dhaka Medical College Hospital (DMCH) and in National Institute of Traumatology and Orthopaedic Rehabilitation (NITOR) over a period of 18 months from January 2010 to June 2011. A total of 18 consecutive patients with histologically proved giant-cell tumour were included in the study. Majority (55.6%) of patient was in 3rd decade and male female ratio was 1:1.3. More than one fourth (27.8%) of the patients had GCT in the lower end of right femur, 33.3% in lower end of left femur, 22.2% in upper end of right tibia, 16.7% in upper end of left tibia and all patients had painful gait and swelling. According to campanacci grading, Grade-2 was found in all patients, and giant cell tumour was found in all patients, as evaluated by pre-operative biopsy. Cosmetically near normal appearance was found in 88.9% and 88.9% were able to do normal daily work. According to Schatzker and Lambert (1979) criteria excellent outcome was found in 38.9%, good in 44.4%, fair in 11.1% and poor in 5.6%. Surgery in the form of intralesional curettage and filling the cavity with bone cement resulted in excellent relief of pain, cosmetically near normal appearance and patients were able to do normal daily work.Faridpur Med. Coll. J. Jan 2017;12(1): 9-13
Abstract:Background & Objectives: Aorto-bi-femoral
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.